Samsung C&T (028260 KS/Buy)Biologics Business Accounts for 73% of Operating Profit
For 3Q25, Samsung C&T reported consolidated revenue of W10.2tr (-1.5% YoY) and operating profit of W993.4bn (+35% YoY), with the latter beating the...
522 Views
Equity Strategy[February] Positioning for the Market’s Next Phase
Because the rally has been primarily earnings-driven, valuation pressure remains limited, with the KOSPI’s 12-month forward P/E standing at 10.6x.
204 Views
Korean Stock Market - The Best Performing Among Major Countries Indices in 2025
We discuss the five most important factors driving the Korean stock market this year which was the best performing among all major country equity...
525 Views
KRX Foreign Holding Weekly (Sep 25th): Samsung Electronics, SK Hynix, SamsungElecMech, SKSQUARE
We analyzed KRX foreign holding data for the past week and highlighted foreign holding changes in Samsung Electronics, SK Hynix, SamsungElecMech,...
106 Views
Progress of 55 Trillion Won Share Buybacks Announced by SK Hynix and Samsung Electronics
According to Korea Exchange KIND reporting on Sept 23, Samsung Electronics repurchased 41.8 million shares over 21 trading days from Aug. 24 to...
506 Views